全文获取类型
收费全文 | 5485篇 |
免费 | 334篇 |
国内免费 | 40篇 |
专业分类
耳鼻咽喉 | 31篇 |
儿科学 | 148篇 |
妇产科学 | 107篇 |
基础医学 | 837篇 |
口腔科学 | 84篇 |
临床医学 | 491篇 |
内科学 | 1453篇 |
皮肤病学 | 109篇 |
神经病学 | 643篇 |
特种医学 | 110篇 |
外科学 | 392篇 |
综合类 | 8篇 |
预防医学 | 270篇 |
眼科学 | 47篇 |
药学 | 509篇 |
中国医学 | 7篇 |
肿瘤学 | 613篇 |
出版年
2024年 | 5篇 |
2023年 | 26篇 |
2022年 | 109篇 |
2021年 | 161篇 |
2020年 | 86篇 |
2019年 | 134篇 |
2018年 | 156篇 |
2017年 | 117篇 |
2016年 | 148篇 |
2015年 | 171篇 |
2014年 | 236篇 |
2013年 | 254篇 |
2012年 | 444篇 |
2011年 | 467篇 |
2010年 | 259篇 |
2009年 | 226篇 |
2008年 | 346篇 |
2007年 | 385篇 |
2006年 | 319篇 |
2005年 | 330篇 |
2004年 | 322篇 |
2003年 | 303篇 |
2002年 | 269篇 |
2001年 | 45篇 |
2000年 | 29篇 |
1999年 | 50篇 |
1998年 | 68篇 |
1997年 | 42篇 |
1996年 | 36篇 |
1995年 | 46篇 |
1994年 | 27篇 |
1993年 | 19篇 |
1992年 | 25篇 |
1991年 | 17篇 |
1990年 | 22篇 |
1989年 | 13篇 |
1988年 | 12篇 |
1987年 | 19篇 |
1986年 | 12篇 |
1985年 | 11篇 |
1984年 | 16篇 |
1983年 | 18篇 |
1982年 | 12篇 |
1981年 | 5篇 |
1980年 | 9篇 |
1979年 | 6篇 |
1973年 | 4篇 |
1971年 | 4篇 |
1967年 | 3篇 |
1966年 | 3篇 |
排序方式: 共有5859条查询结果,搜索用时 2 毫秒
1.
2.
Maria Grazia Daidone Rosella Silvestrini Nadia Zaffaroni Egle Grignolio Fabio Landoni 《Investigational new drugs》1987,5(3):245-250
An in vitro assay, which evaluates drug effect on 3H-thymidine incorporation, was used to investigate the absolute and relative activities of cisplatin (DDP), carboplatin (CBDCA) and iproplatin (CHIP) on 317 specimens from untreated tumors, including breast and ovarian cancers and malignant melanomas. Similar activities were generally observed for DDP and CHIP, whereas CBDCA exhibited a lower, although not significantly different cytotoxicity on breast and ovarian cancers. The relative activities of Platinum analogues were analyzed on 239 two-way drug sensitivity comparisons. The overall agreement rates ranged from 80.2 to 83.9% for the different comparisons. High coresistance, from 61.1 to 93.8%, was observed for all the comparisons, regardless of the tumor type. Cosensitivity rates were poor for breast and ovarian cancers, from 0 to 37.5%, whereas for melanomas an association in sensitivity was observed in 80% of the cases. 相似文献
3.
Object recognition is one of the most important functions of the human visual system, yet one of the least understood, this despite the fact that vision is certainly the most studied function of the brain. We understand relatively well how several processes in the cortical visual areas that support recognition capabilities take place, such as orientation discrimination and color constancy. This paper proposes a model of the development of object recognition capability, based on two main theoretical principles. The first is that recognition does not imply any sort of geometrical reconstruction, it is instead fully driven by the two dimensional view captured by the retina. The second assumption is that all the processing functions involved in recognition are not genetically determined or hardwired in neural circuits, but are the result of interactions between epigenetic influences and basic neural plasticity mechanisms. The model is organized in modules roughly related to the main visual biological areas, and is implemented mainly using the LISSOM architecture, a recent neural self-organizing map model that simulates the effects of intercortical lateral connections. This paper shows how recognition capabilities, similar to those found in brain ventral visual areas, can develop spontaneously by exposure to natural images in an artificial cortical model. 相似文献
4.
Carla Ghelardini Alessandro Quattrone Nicoletta Galeotti Silvia Livi Grazia Banchelli Laura Raimondi Renato Pirisino 《Neuropsychopharmacology》2003,28(6):1096-1105
Amphetamine (AMPH) is an indirect sympathomimetic compound classified as a substrate-type releaser that distinguishes it from other stimulants that act as uptake 1 blockers, such as cocaine (COC). In mammals, AMPH elicits central stimulation, hypermotility, anorexia, analgesia and analeptic activity, mainly through the increase of extracellular brain dopamine (DA). The inversion of vesicular transporters and/or intravesicular alkalinization is assumed to have a role in AMPH-induced exocytosis. However, the action mechanism of this compound has not yet been completely clarified. Recent evidence on the action of AMPHs indicates potassium channel-blocking properties in peripheral tissues. We investigated the possible involvement of a Shaker-like Kv1.1 channel subtype in the central effects of AMPH, using an antisense oligodeoxyribonucleotide (aODN) that specifically and reversibly inhibits the expression of these channels in the brain. The effect of aODN pretreatments was studied by evaluating the modification of behavioral effects induced in mice through the intracerebroventricular administration of AMPH, COC, or other compounds. The aODN in mice almost completely blocked the stimulatory effects of AMPH and other releasers but was ineffective in reducing the central activity of COC. In aODN-pretreated rats a strong reduction of the AMPH, but not of the COC-stimulated DA efflux from nucleus accumbens was observed. Our results suggest that the stimulant effects of AMPH and chemically related compounds, but not COC, require the presence of functionally active Kv1.1 channels in the brain. 相似文献
5.
6.
Tancredi M Sensi E Cipollini G Aretini P Lombardi G Di Cristofano C Presciuttini S Bevilacqua G Caligo MA 《European journal of human genetics : EJHG》2004,12(9):775-777
Germ-line mutations in the BRCA1 gene cause hereditary predisposition to breast and ovarian cancer. BRCA1 and BRCA2 mutations account for about 40% of high-risk families. Mutation-screening methods generally focus on genomic DNA and are usually PCR based; they enable the detection of sequence alterations such as point mutations and small deletions and insertions. However, they do not allow the detection of partial or entire exon(s) loss, because the presence of the homologous allele results in a positive PCR signal, giving rise to a false-negative result. Identification of unusual haplotypes in patient samples by an expectation maximization algorithm has recently been suggested as a method for identifying hemizygous regions caused by large intragenic deletions. Using a similar approach, we identified a novel BRCA1 genomic rearrangement in a breast/ovarian cancer family negative at the first mutation screening; we detected a deletion encompassing exons 14-19, probably due to replication slippage between Alu sequences. 相似文献
7.
Maria Rosaria Raspollini Gianni Amunni Alessandro Villanucci Francesca Castiglione Duccio Rossi Degl'Innocenti Gianna Baroni Milena Paglierani Gian Luigi Taddei 《Applied immunohistochemistry & molecular morphology》2006,14(2):181-186
The bcl-2 protein is a membrane protein involved in prolonging cell survival by inhibiting apoptosis. The HER-2 oncogene, which is located on chromosome 17 and encodes for a tyrosine-kinase growth factor receptor, is amplified and HER-2/neu is overexpressed in 25% to 30% of breast carcinomas. The authors analyzed the bcl-2 expression and the bcl-2 gene and HER-2/neu overexpression and amplification in FIGO stage IIIC, serous, G3, ovarian carcinomas obtained from living patients who had no evident disease 5 years after primary treatment compared with ovarian carcinomas obtained from patients, matched for stage, grade of differentiation, and treatment, who had died of progression of disease no later than 2 years after primary treatment. bcl-2 overexpression was statistically correlated with progression of disease during first-line chemotherapy (P=0.021). The HER-2/neu status was found not to correlate with progression of disease during first-line chemotherapy. Both bcl-2 and HER-2/neu expression were not statistically associated with the clinical outcome of ovarian cancer patients. Gene amplification of the HER-2/neu chromosome 17 was found in all the HER-2/neu, 3+ score, positive-staining ovarian carcinomas. None of the analyzed samples revealed a translocation t(14;18)(q32;q21) in the bcl-2 gene. The knowledge of additional prognostic or even predictive factors, such as bcl-2 expression, in patients with advanced ovarian carcinoma before the primary chemotherapeutic treatment may help in the management of patients who require a more tailored treatment. In addition, the gene amplification of the HER-2/neu suggests that HER-2 is a potential target for treatment in ovarian cancer. 相似文献
8.
Raspollini MR Castiglione F Garbini F Villanucci A Amunni G Baroni G Boddi V Taddei GL 《International journal of surgical pathology》2005,13(2):135-142
We analyzed in advanced ovarian serous G3 carcinoma the correlation between epidermal growth factor receptor (EGFR) overexpression and tumor angiogenesis and their relation with clinical outcome. Microvessel density (MVD) and vascular endothelial growth factor (VEGF) were statistically correlated with disease-free interval and death from disease both in univariate and multivariate analyses while EGFR expression was not correlated with clinical outcome. MVD was significantly associated with progression of disease during chemotherapy while VEGF and EGFR expression were not correlated with responsiveness to chemotherapy (Fisher's exact test). VEGF expression was correlated with MVD (Fisher's exact test). EGFR showed a trend to correlation with MVD. Further studies focusing on the use of angiogenesis inhibitors in addition to EGFR inhibitors on ovarian carcinoma cells may produce therapeutic strategies in the selection of tailored therapies in ovarian cancer patients. 相似文献
9.
Stefania Damiani Maria Grazia Cattani Laura Buonamici V. Eusebi 《Virchows Archiv : an international journal of pathology》1998,432(5):433-440
Cells showing abundant, finely vacuolized cytoplasm (foam cells) are found frequently in most benign lesions of the breast
and in certain malignant breast tumours. The origin of mammary foam cells (FCs) has not been clarified, and we therefore studied
the morphological features of mammary FCs in a series of 50 benign lesions. The FCs were subdivided, on the basis of their
distribution into FCs lining the glandular lumina, intraluminal FCs, intraepithelial-pagetoid FCs, and stromal FCs. The lesions
were tested with a panel of antibodies against macrophage (MAC 387, CD68) and epithelial (epithelial membrane antigen [EMA],
gross cystic disease fluid protein 15 [GCDFP15] and cytokeratin) markers. The lesions were examined for the presence of PIP/GCDFP15-specific
mRNA by an in situ hybridization technique. Three different types of FCs were identified. Type A FCs are epithelial cells
(positivity with EMA and cytokeratin) and show apocrine differentiation (positivity with GCDFP15 antiserum and expression
of PIP/GCDFP15 mRNA). Type B FCs are of macrophage origin, as they are positive with the macrophage markers and lack cytokeratin
and PIP/GCDFP15 mRNA. Finally, type C FCs show an intermediate profile between an epithelial cell and a macrophage: they are
both CD68 and GCDFP15 positive and show a thin peripheral rim of positivity with anti-cytokeratin antibody. They lack PIP/GCDFP15
mRNA. Our results indicate the possibility of a spectrum of phenotypes in mammary FCs, from epithelial-apocrine cells to macrophage-derived
phagocytic cells.
Received: 19 September 1997 / Accepted: 29 December 1997 相似文献
10.
Human Cytomegalovirus and Human Umbilical Vein Endothelial Cells: Restriction of Primary Isolation to Blood Samples and Susceptibilities of Clinical Isolates from Other Sources to Adaptation 下载免费PDF全文
Giuseppe Gerna Elena Percivalle Antonella Sarasini M. Grazia Revello 《Journal of clinical microbiology》2002,40(1):233-238
In immunocompromised patients with disseminated infection, human cytomegalovirus (HCMV) is widespread in the microvascular endothelium of multiple organs. Human umbilical vein endothelial cells (HUVEC) were used in parallel to human embryonic lung fibroblasts (HELF) to recover HCMV from blood samples of immunocompromised patients. Using the shell vial technique, comparable median numbers of p72-positive HUVEC and HELF cells were found with the 26 HCMV-positive buffy coat samples out of 150 examined. Analysis of other clinical samples inoculated as controls revealed, in the presence of highly infected HELF monolayers, either the presence of very few infected HUVEC with urine specimens (n = 10 samples) or the lack of infected HUVEC with throat washes (n = 3) or amniotic fluid samples (n = 2). Thus, peripheral blood leukocytes (PBL) appear essential for primary isolation of HCMV in HUVEC. In this respect, HCMV strains, recovered from clinical samples other than buffy coats in HELF only, could be readily adapted to growth in HUVEC by coculturing PBL from healthy blood donors with infected HELF and then inoculating infected PBL onto HUVEC. Recently elucidated mechanisms of interaction of leukocytes and HUVEC with bidirectional transfer of virus seem to provide the basis for the restriction of HCMV primary isolation in HUVEC to blood samples. However, virus strains recovered from only HELF could be adapted to growth in HUVEC when inoculated with HELF-derived (either cell-associated or cell-free) HCMV strains upon primary isolation. In conclusion, due to the in vitro selection of virus variants provided with both PBL tropism and HUVEC tropism, HCMV recovery in HUVEC is PBL mediated and substantially restricted to blood samples. Lack of HCMV recovery in HUVEC from clinical samples other than blood leads to the assumption that epithelial cells, such as urinary, amniotic, or pharyngeal cells, do not possess adequate adhesion molecules to establish close contacts with HUVEC. 相似文献